Daiwa Securities Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Daiwa Securities Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-301	Closed	-$41K	–	1311
2020 Q3	$41K	Buy	301 +40	+15%	+$4.25K	﹤0.01%	950
2020 Q2	$12K	Hold	261	–	–	﹤0.01%	1061
2020 Q1	$12K	Hold	261	–	–	﹤0.01%	1052
2019 Q4	$19K	Sell	261 -29	-10%	-$1.76K	﹤0.01%	1018
2019 Q3	$15K	Hold	290	–	–	﹤0.01%	1011
2019 Q2	$15K	Buy	290 +34	+13%	+$1.66K	﹤0.01%	1033
2019 Q1	$13K	Buy	256 +58	+29%	+$2.67K	﹤0.01%	1020
2018 Q4	$10K	Hold	198	–	–	﹤0.01%	1002
2018 Q3	$13K	Hold	198	–	–	﹤0.01%	1020
2018 Q2	$10K	Hold	198	–	–	﹤0.01%	1055
2018 Q1	$10K	Buy	+198	New	+$10.3K	﹤0.01%	1034

Daiwa Securities Group's MYOK Position: Q4 2020 in Review

Daiwa Securities Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 301 shares — an estimated $41K sold.

Daiwa Securities Group first reported a position in MYOK in Q1 2018 and held it in 11 quarters. The position peaked at $41K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Daiwa Securities Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Daiwa Securities Group sold 301 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $41K.
Daiwa Securities Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 11 quarters.
Daiwa Securities Group's MyoKardia, Inc. Common Stock position peaked at $41K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.